Skip to content
Search

Latest Stories

Alice Hare joins Alitam’s executive board

Alitam has announced the appointment of the former head of operations at Well Pharmacy, Alice Hare, to its executive board.

She joins Alitam as head of services mobilisation and boasts an impressive resume, with highlights including the establishment of all new and innovative operating models throughout her 25-year career within community pharmacy.


Alice has previously led on a variety of partnerships delivering a futuristic model of primary care which better positions community pharmacy as the first port of call for patients.

Alitam founder and CEO Feisal Nahaboo said: “Alice brings with her the skills, knowledge and experience to excel in her new role, which will see her helping drive the transformation of the group’s pharmacies towards fully fledged clinical and wellbeing services.

He said: “Alice is the perfect fit for Alitam, and a huge advocate of our movement to revolutionise healthcare by fully utilising highly skilled and experienced community pharmacists. She contacted me having seen our work at the vanguard of innovation, most recently with our roll-out of GP-type clinical services like Minor Ailments Clinics, diabetes checks, weight loss clinics and more in Alitam stores.

“It’s no understatement to say that, as soon as we met, we realised it was a meeting of minds. Alice has the acute intelligence, crucial experience and personable qualities to render her ideal for this role. She will be instrumental in transforming our community pharmacies from their product-based offering to one of clinical and wellbeing services, and will work closely with out Chief Operating Officer Bharti Patel in this regard.

“Many Alitam pharmacies already offer ‘GP-type’ services, of course, but Alice will be ensuring all pharmacies incorporate them where feasible.

“Alice will also work ‘at the coalface’ with every one of our pharmacies, guiding them through the process of widening their clinical repertoire, and enabling the cross- fertilisation of ideas and experiences which is in the Alitam DNA.

“With her engaging manner, and boundless enthusiasm, Alice will be a real asset to Alitam.”

Alice is fulsome in her praise of Nahaboo and his multi-billion-pound ‘Pharmacy of the Future’ concept, which will see the launch of a chain of ‘Super Pharmacies’ across the UK and Ireland over the next decade and which will embed preventative healthcare by drawing upon the skills and expertise of “underutilised” pharmacists.

She said: “I’ve been waiting for an opportunity such as this for a long time. “It’s long been obvious to me that pharmacies are uniquely equipped to plug the enormous gap in healthcare which leaves many of our citizens are needlessly suffering—most especially in the wake of the Covid-19 pandemic.

“Feisal’s radical vision for healthcare is precisely what’s needed right now, and it’s galvanising pharmacies in a way I’ve not seen before. The Alitam Group is nimble, incredibly close-knit and highly motivated - I couldn’t be more delighted to be part of the management team.”

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less